Clinical Trial Update: Multicentre Phase III Erythropoietic Protoporphyria Study [Phase 3]

View source ↗

Summary

A multicentre Phase III trial in erythropoietic protoporphyria has completed, with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythropoietic Protoporphyria

Drugs mentioned

• Clinuvel Pharmaceuticals Limited

Snippet

Sponsor: Clinuvel Pharmaceuticals Limited | Conditions: Erythropoietic Protoporphyria | Phase 3 | Status: COMPLETED | Results posted: 2019-10-10